# Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis

> **NCT00732069** · PHASE2 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 19 (actual)

## Conditions studied

- End Stage Renal Failure on Dialysis
- Complication of Hemodialysis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Ramipril
- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT00732069
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2013-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00732069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00732069, "Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00732069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*